Mr. Speaker, I want to come back to the issue around the Conservative policy and also address the issue that the member for Pictou—Antigonish—Guysborough refuses to comment on. That is the very negative impact on health care in Canada today and the prices of drugs as a result of the Mulroney government's decision to dismantle what was then considered to be one of the best drug laws and best patent protection systems around, which ensured that not only were Canadian companies competitive internationally, but were able to provide reasonable access to Canadians.
The facts are very clear with regard to Bill C-22 and Bill C-91, that Mulroney government really jettisoned legislation that ensured competition between foreign and domestic drug companies, served most Canadians well. The only thing that has gone up since the Mulroney legislation is the prices and the profit margins for the big corporations.
Would the member account for that kind of failed policy and indicate whether he is now prepared to get with it and support us in opposing this bill?